Author

G. Lozanski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 6

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 6 Approach:experimental assay· 5 Organism:human· 4 Assay:proteomics· 4 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

C. Carlin· 6 shared E. M. Oltz· 6 shared J. P. Evans· 6 shared L. J. Saif· 6 shared R. J. Gumina· 6 shared S.-L. Liu· 6 shared P. Qu· 5 shared Y.-M. Zheng· 5 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersMicrobiology

C. Carlin

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants

P. Qu, J. N. Faraone, J. P. Evans, Y.-M. Zheng, C. Carlin, M. Anghelina, P. Stevens, S. Fernandez, D. Jones, G. Lozanski, A. Panchal, L. J. Saif, E. M. Oltz, K. Xu, R. J. Gumina, S.-L. Liu

This study evaluates neutralizing antibody escape by Omicron subvariants XBB.1.5, CH.1.1, and CA.3.1, showing near-complete escape from mRNA vaccines but partial rescue with bivalent boosters.

bioRxiv · Jan 16, 2023 · PreprintMicrobiology

Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2

P. Qu, J. P. Evans, J. Faraone, Y.-M. Zheng, C. Carlin, M. Anghelina, P. Stevens, S. Fernandez, D. Jones, G. Lozanski, A. Panchal, L. J. Saif, E. M. Oltz, K. Xu, R. J. Gumina, S.-L. Liu

This study evaluates neutralization resistance and immune evasion mechanisms of SARS-CoV-2 Omicron subvariants against various sera, identifying key mutations driving resistance.

bioRxiv · Oct 19, 2022 · PreprintMicrobiology

Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants

P. QU, J. N. Faraone, J. P. Evans, Y.-M. Zheng, C. Carlin, G. Lozanski, L. J. Saif, E. M. Oltz, R. J. Gumina, S.-L. Liu

This study examines the durability of neutralizing antibody responses to SARS-CoV-2 BA.2.12.1 and BA.4/5 variants after mRNA booster vaccination, finding significant waning but stable responses compared to two-dose immunity.

bioRxiv · Jul 21, 2022 · PreprintMicrobiology

Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

P. Qu, J. P. Evans, J. N. Faraone, X. Zou, Y.-M. Zheng, C. Carlin, J. S. Bednash, G. Lozanski, R. K. Mallampalli, L. J. Saif, E. M. Oltz, P. J. Mohler, R. J. Gumina, S.-L. Liu

This study compares the neutralization resistance, infectivity, and fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 subvariants to other variants and finds increased resistance and fusogenicity linked to L452 mutations.

bioRxiv · May 16, 2022 · PreprintMicrobiology

Neutralization and Stability of SARS-CoV-2 Omicron Variant

Z. Cong, J. P. Evans, P. Qu, J. Faraone, Y.-M. Zheng, C. Carlin, J. S. Bednash, T. Zhou, G. Lozanski, R. Mallampalli, L. J. Saif, E. M. Oltz, P. Mohler, K. Xu, R. J. Gumina, S.-L. Liu

This study investigates the immune evasion and transmissibility of the SARS-CoV-2 Omicron variant, showing significant immune evasion but restored neutralization with booster doses and increased transmissibility due to a more stable spike protein structure.

bioRxiv · Dec 16, 2021 · PreprintMicrobiology

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

J. P. Evans, C. Zeng, C. Carlin, G. Lozanski, L. J. Saif, E. M. Oltz, R. J. Gumina, S.-L. Liu

This study examines the decline of neutralizing antibody responses to SARS-CoV-2 variants after mRNA vaccination and shows that breakthrough infection boosts antibody levels.

bioRxiv · Dec 6, 2021 · PreprintMicrobiology